IA
IART icon

Icon Advisers’s Integra LifeSciences IART Stock Holding History

Icon Advisers’s Portfolio IART Stock Details IART Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-17,000
Closed -$941K – 318
2018
Q1 		$941K Hold
17,000
– – 0.07% 225
2017
Q4 		$814K Buy
+17,000
New +$832K 0.06% 257

Other funds holding IART

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Icon Advisers's IART Position: Q2 2018 in Review

Icon Advisers sold out of Integra LifeSciences (IART) in Q2 2018, closing a stake of 17,000 shares — an estimated $941K sold.

Icon Advisers first reported a position in IART in Q4 2017 and held it in 2 quarters. The position peaked at $941K in Q1 2018. 257 funds tracked by Wall St. Rank hold IART as of Q2 2018.

  • Icon Advisers reported no remaining Integra LifeSciences position as of Q2 2018 after selling out during the quarter.
  • Icon Advisers sold 17,000 Integra LifeSciences shares in Q2 2018, an estimated $941K.
  • Icon Advisers first reported a position in Integra LifeSciences in Q4 2017 and held it in 2 quarters.
  • Icon Advisers's Integra LifeSciences position peaked at $941K in Q1 2018.
  • 257 funds tracked by Wall St. Rank held Integra LifeSciences as of Q2 2018.

Based on Icon Advisers's 13F filing for Q2 2018, filed 3 Aug 2018.